| <img alt="" height="1" width="1" />Ironwood Pharmaceuticals Files Annual Report on Form 10-KMarketWatch (press release)Linaclotide, Ironwood's first-in-class GC-C agonist, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with ...<nobr>and more »</nobr> |
Google- Ironwood Pharmaceuticals Files Annual Report on Form 10-K - MarketWatch (press release)
1 - 1 of 1 Posts
1 - 1 of 1 Posts
- This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
Join the discussion
Irritable Bowel Syndrome and Digestive Health Support Forum
A forum community dedicated to Irritable Bowel Syndrome and Digestive Health Support. Come join the discussion about treatment, diet, health, lifestyles, spirituality, medication, research, recovery, and more!
Full Forum Listing
Recommended Communities
Join now to ask and comment!